Sort
51,593 grants matching “hepatitis”
Reducing Youth Drug Related HIV/STD Risk in Thailand
$685,707Johns Hopkins University · R01 · FY2004 · DA
HUMAN REQUIREMENTS FOR THE NUTRIENT CHOLINE
$685,688University Of North Carolina Chapel Hill · R01 · FY2001 · DK
Nuclear receptors: action, functions, and roles in disease
$685,660Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
PROTEOMICS CORE
$685,604Richard Daniel Carliss · University Of Washington · P30 · FY2011 · DA
Improving HIV and Alcohol-Related Outcomes among HIV+ Persons in Clinic Settings
$685,598Jeffrey T Parsons · Hunter College · R01 · FY2015 · AA
Control of vesicular trafficking in the hepatocyte
$685,454Allan W Wolkoff · Albert Einstein College Of Medicine · R01 · FY2021 · DK
Control of vesicular trafficking in the hepatocyte
$685,454Allan W Wolkoff · Albert Einstein College Of Medicine · R01 · FY2022 · DK
Control of vesicular trafficking in the hepatocyte
$685,454Allan W Wolkoff · Albert Einstein College Of Medicine · R01 · FY2020 · DK
Nutrition Infection and Hepatic Carbohydrate Metabolism
$685,418Owen P McGuinness · Vanderbilt University · R01 · FY2010 · DK
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer
$685,408Anna M Wu · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Pathogenesis of Liver Disease in Hepatitis
$685,357Francis Vincent Chisari · Scripps Research Institute, The · R01 · FY2008 · AI
Cytochrome P-450 Polymorphism
$685,319Eric F Johnson · Scripps Research Institute, The · R01 · FY2008 · GM
Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative U01 Grant
$685,269Steven Kyle Grinspoon · Massachusetts General Hospital · U01 · FY2017 · AI
Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative U01 Grant
$685,269Steven Kyle Grinspoon · Massachusetts General Hospital · U01 · FY2016 · AI
Cognitive Function, Self-Management, and Health Outcomes among Liver Transplant Recipients: the LivCog Cohort
$685,252Marina Serper · University Of Pennsylvania · R01 · FY2025 · DK
Chip phosphorylation stimulates the degradation of mutant transthyretin to attenuate cardiac amyloidosis
$685,249Mark John Ranek · Johns Hopkins University · R01 · FY2025 · HL
Development of RNAi based sFLT1-targeting therapeutics for treatment of Preeclampsia
$685,210Anastasia Khvorova · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · HD
A Cytomegalovirus-based therapeutic vaccine for chronic hepatitis B
$685,089Eric Bruening · Tomegavax, Inc. · R44 · FY2018 · AI
Cryopreservation and nanowarming enables whole liver banking for transplantation, cell therapy and biomedical research
$685,071Erik Brian Finger · University Of Minnesota · R01 · FY2023 · DK
Pathogenesis of Parenteral Viral Hepatitis
$684,996Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Hepatitis C Pathogenesis &The Human Genome
$684,869Johns Hopkins University · R01 · FY2005 · DA
Soft drusen in rhesus macaques as a nonhuman primate model of early age-related macular degeneration
$684,798Glenn Yiu · University Of California At Davis · R01 · FY2023 · EY
Development of a FRET based Bile Salt Export Pump Inhibition Liposomal Assay
$684,797Praveen Bansal · Tfc Biosciences, Inc. · R44 · FY2020 · GM
Development of an Adenovirus based HCV Vaccine: preclinical safety and immunology
$684,720Alfredo Nicosia · Irbm P Angeletti, Spa · U01 · FY2006 · AI
The Epitranscriptome as a Novel Mechanism of Arsenic-Induced Diabetes.
$684,582Ana Navas-Acien · Columbia University Health Sciences · R01 · FY2021 · ES